Krasney Karen sold CAPR
June 24, 2026 · Form 4 insider transaction
Krasney Karen sold 400 shares of Capricor Therapeutics, Inc. at $30.00 per share, a transaction worth $12.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
400
Price
$30.00
Total value
$12.0K
InsiderKrasney Karen
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 24, 2026
Filing dateJune 24, 2026
Shares owned after30,547
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.